ESOPs in India: The CS Playbook for Listed and Unlisted Companies (2026 Edition)

ESOPs are where four bodies of law meet: Companies Act + Rules, SEBI's SBEB-SE Regulations (for listed entities), Income Tax provisions on perquisite valuation, and the contractual layer the company writes for its employees. The CS is usually the one person in the company who can hold all of it together. This is the playbook from scheme design to exercise — for listed and unlisted companies.

The two parallel regimes

• Unlisted companies: Section 62(1)(b) of the Companies Act + Rule 12 of the Companies (Share Capital and Debentures) Rules. Scheme adoption by special resolution, board administers, no specific external trustee requirement.
• Listed companies: SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 — the SBEB-SE Regs — plus Sections 62(1)(b) and Section 67. Trust route or direct route. Compensation Committee mandated, not just optional.

Designing a scheme — the seven choices that matter

1. Pool size. Typically 8–15% of fully diluted equity for early-stage; 2–5% for mature listed companies. Anchor to dilution comfort, not market practice alone.
2. Vesting profile. Four-year vest with one-year cliff is industry default. Founders sometimes prefer five-year for retention; engineering-heavy teams prefer four with monthly post-cliff.
3. Exercise price. Below FMV at grant: a discount taxable as perquisite. At FMV: cleaner tax treatment. Below face value: not permitted.
4. Exercise window post-vesting. Typically 5–7 years. Listed companies often choose shorter; unlisted longer (since liquidity comes only at an event).
5. Treatment on exit. Voluntary resignation forfeits unvested; termination for cause forfeits all; death / disability accelerates. The most disputed clause in any scheme; draft carefully.
6. Acceleration on change of control. Single trigger (acceleration on CoC), double trigger (acceleration only if CoC + termination within X months), or none. Affects the M&A deal price more than founders realise.
7. Cashless exercise. Practical for listed; harder for unlisted. Tax timing implications.

The unlisted-company lifecycle

1. Board adopts the scheme — board resolution at duly-convened meeting.
2. Shareholders approve — special resolution. MGT-14 within 30 days.
3. Grant letters — issued to identified employees. Grant date is the date of board's grant approval.
4. Vesting tracking — typically quarterly or monthly. Keep a master grant register.
5. Exercise — employee files exercise notice + payment of exercise price.
6. Allotment — board allots shares. PAS-3 within 30 days of allotment.
7. Issue of share certificates — within 2 months of allotment (Section 56(4)).
8. Register update — Register of Members (MGT-1), Register of ESOP (SH-6).

The listed-company lifecycle

1. Board adopts scheme.
2. Shareholder approval via special resolution. Disclosure under SBEB-SE Regulation 6.
3. In-principle approval from stock exchanges for listing of underlying shares.
4. Compensation Committee administers — grants, exercises, treatment on exit.
5. Insider trading window discipline. Grants and exercises only outside the trading window for designated persons. Plan against the results calendar.
6. SBEB-SE annual compliance certificate from secretarial auditor in the annual report.
7. Listing application for new shares on each allotment.
8. BRR / BRSR disclosures where applicable.

The tax architecture (relevant for CS-CFO coordination)

• At grant: no tax event for the employee.
• At exercise: perquisite under Section 17(2)(vi) — (FMV on exercise date – exercise price). Taxable in the year of exercise.
• For eligible startups (DPIIT recognised + Section 80-IAC): tax on perquisite is deferred to the earliest of (a) 5 years from exercise, (b) sale of shares, (c) cessation of employment. A meaningful benefit.
• At sale: capital gains — long-term if held > 12 months for listed, > 24 months for unlisted, post-exercise.

The seven most common CS mistakes

1. Grant date confusion between board resolution date and grant letter date.
2. PAS-3 missed when exercised in tranches.
3. Forgetting MGT-14 on the scheme adoption resolution.
4. Insider trading window collision — grants made during a closure window without realising it.
5. SH-6 register either non-existent or not updated.
6. FMV computation by the registered valuer not refreshed annually (unlisted).
7. Treatment on leaving employee disputed because the scheme didn't define “cause” or “good leaver.”

The 2022–2025 SBEB-SE amendments and what they changed

• Trust route requirements clarified — trusts cannot acquire shares from secondary market beyond regulated limits.
• Disclosure requirements expanded — granular table of grants, exercises, lapses by senior management and key managerial personnel.
• Insider trading framework integrated more tightly — defined the “contra trade” treatment for exercise + sale within 6 months.
• Sweat equity rules tightened for listed companies — disclosures and shareholder approval thresholds raised.

How Delta Filings handles ESOP administration

The Delta Filings cap table and ESOP module tracks every grant, every vesting milestone, every exercise; auto-drafts the PAS-3 on allotment; flags trading-window conflicts for listed companies; and produces the SBEB-SE disclosure schedule in the SEBI-prescribed format. For a CS administering a scheme across 200+ employees, the reduction in calendar-driven errors is the single most useful change.

The closing note

ESOPs go wrong slowly. The scheme is adopted clean. The first 50 grants are clean. By the time the first exercise happens, three years have passed, the original scheme champion has left, the new CS inherits an undocumented mess, and the auditor starts asking questions during the IPO diligence. The fix is to over-document at adoption and to keep the register live. Both are CS jobs.